Tristel plc (TSNLF) Q4 2025 Earnings Call Transcript

Operator

Good morning, and welcome to the Tristel plc investor presentation. [Operator Instructions] Before we begin, I’d like to submit the following poll. I’d now like to hand you over to Matt Sassone, CEO. Good morning, sir.

Matthew Sassone
CEO & Director

Good morning, and thank you to everyone joining us online. This is Tristel plc’s preliminary results presentation. And I’m delighted to say that I’m joined by our new CFO, Anna Wasyl. And what I’ll quickly do is ask Anna to introduce herself and to say a few words on the first impressions of the company.

Anna Wasyl
Chief Financial Officer

Thank you, Matt. Yes, I just completed my 6 weeks at Tristel. It has been a very exciting and busy time, but really, really great. So as you can see here on the slide, I came from CMR Surgical, where I held positions of both CFO and Chief Commercial Officer for some time. And yes, I’m really excited to join Tristel. I think it’s a really critical time because of our increased traction in the U.S. and all the opportunities that the U.S. market is giving us. I’m the type of CFO, who is quite interested in commercial models, in looking at different market entry strategies. So I’m really keen to support Matt in that growth journey.

Matthew Sassone
CEO & Director

Excellent. Wonderful. Well, let’s crack on with the presentation. I appreciate the vast majority of you online are very aware about the Tristel story, but hopefully, we have 1 or 2 new people. We are a global infection prevention company, focused on sort of like addressing the transmission of microbes between people, objects, et cetera. The way that we